Cargando…
Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modifie...
Autores principales: | Segelov, Eva, Chan, David, Lawrence, Ben, Pavlakis, Nick, Kennecke, Hagen F., Jackson, Christopher, Law, Calvin, Singh, Simron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560462/ https://www.ncbi.nlm.nih.gov/pubmed/28831446 http://dx.doi.org/10.1200/JGO.2016.006916 |
Ejemplares similares
-
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care
por: Del Rivero, Jaydira, et al.
Publicado: (2023) -
Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
por: Al-Efraij, Khalid, et al.
Publicado: (2015) -
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023) -
Collaborative Practice in the Management of Neuroendocrine Tumors
por: Chan, Jennifer A., et al.
Publicado: (2016) -
Severe Thrombocytopenia in Patients With Advanced Neuroendocrine Tumor Treated With Peptide Receptor Radioligand Therapy
por: Naveed Ahmad, Junid A., et al.
Publicado: (2022)